PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 9 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Clinical evidence
Essential oils with low pulegone content showed antifungal activity, particularly against Epidermophyton floccosum (MIC/MLC 0.63 microL mL-1) [PMID:17680495].
Essential oils were active against Staphylococcus aureus, Streptococcus pyogenes, Escherichia coli, Streptococcus typhimurium, and Candida albicans, with MIC as low as 0.025mg/ml for S. aureus and S. pyogenes [PMID:30792999].
Hydromethanolic extracts exhibited cytotoxicity against four tested tumor cell lines, although infusions showed no cytotoxicity [PMID:27110832].
Evidence summary
PubMed sources
- 1.PMID: 36839664 (2023) — Essential Oils from Côa Valley Lamiaceae Species: Cytotoxicity and Antiproliferative Effect on Glioblastoma Cells. · Pharmaceutics
- 2.PMID: 33804017 (2021) — Phenolic Compounds and Biological Activity of Selected Mentha Species. · Plants (Basel, Switzerland)
- 3.PMID: 37514203 (2023) — Monitoring Genetic Erosion of Aromatic and Medicinal Plant Species in Alentejo (South Portugal). · Plants (Basel, Switzerland)
- 4.PMID: 17680495 (2007) — Composition and antifungal activity of the essential oil of Mentha cervina from Portugal. · Natural product research
- 5.PMID: 27110832 (2016) — Chemical characterization and bioactive properties of two aromatic plants: Calendula officinalis L. (flowers) and Mentha cervina L. (leaves).